JoVE Logo

Sign In

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

1.4K Views

09:06 min

February 3rd, 2023

DOI :

10.3791/65047-v

February 3rd, 2023


Explore More Videos

68Gallium

Chapters in this video

0:00

Introduction

1:09

68Ga Radiolabeling

1:58

Tracer Stability Test

3:01

Cellular Uptake Experiment

4:33

Positron Emission Tomography (PET) Imaging

5:50

Ex Vivo Biodistribution

6:42

Results: Analyzing In Vivo Binding Affinity, Stability, and Imaging Capacity of [68Ga]DPA

8:38

Conclusion

Related Videos

article

11:22

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

9.9K Views

article

08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

17.3K Views

article

10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

8.7K Views

article

06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

11.1K Views

article

09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

272 Views

article

11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

8.7K Views

article

09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

1.2K Views

article

08:33

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

12.9K Views

article

07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

6.9K Views

article

07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging

6.4K Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved